Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union
| Autor: | Byrd, Richard A., Owens, Rebecca A., Blackbourne, Jamie L., Coutant, David E., Farmen, Mark W., Michael, M. Dodson, Moyers, Julie S., Schultze, A. Eric, Sievert, Michael K., Tripathi, Niraj K., Vahle, John L. |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology August 2017 88:56-65 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect